Parasellar Meningiomas.
Graillon T, Regis J, Barlier A, Brue T, Dufour H, Buchfelder M.
Neuroendocrinology. 2020;110(9-10):780-796. doi: 10.1159/000509090. Epub 2020 Jun 3.
Craniopharyngiomas.
Hamblin R, Tsermoulas G, Karavitaki N.
Presse Med. 2021 Dec;50(4):104078. doi: 10.1016/j.lpm.2021.104078. Epub 2021 Oct 22.
Craniopharyngiomas.
Lithgow K, Hamblin R, Pohl U, Karavitaki N.
2022 Feb 26. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Radiotherapy of Parasellar Tumours.
Albano L, Losa M, Flickinger J, Mortini P, Minniti G.
Neuroendocrinology. 2020;110(9-10):848-858. doi: 10.1159/000506902. Epub 2020 Mar 4.
Craniopharyngiomas.
Karavitaki N, Cudlip S, Adams CB, Wass JA.
Endocr Rev. 2006 Jun;27(4):371-97. doi: 10.1210/er.2006-0002. Epub 2006 Mar 16.
Benign brain tumors: sellar/parasellar tumors.
Jagannathan J, Kanter AS, Sheehan JP, Jane JA Jr, Laws ER Jr.
Neurol Clin. 2007 Nov;25(4):1231-49, xi. doi: 10.1016/j.ncl.2007.07.003.
Histopathology of Parasellar Neoplasms.
Manojlovic-Gacic E, Rostami E, Karavitaki N, Casar-Borota O.
Neuroendocrinology. 2020;110(9-10):740-752. doi: 10.1159/000507084. Epub 2020 Mar 11.
Craniopharyngioma.
Jane JA Jr, Laws ER.
Pituitary. 2006;9(4):323-6. doi: 10.1007/s11102-006-0413-8.
Risk of Tumor Progression after Microsurgery for Parasellar Meningioma Invading the Cavernous Sinus.
Nowak A, Maj E, Marchel A, Kunert P.
Cancers (Basel). 2024 Jun 14;16(12):2217. doi: 10.3390/cancers16122217.
Craniopharyngioma in adults.
Zoicas F, Schöfl C.
Front Endocrinol (Lausanne). 2012 Mar 29;3:46. doi: 10.3389/fendo.2012.00046. eCollection 2012.
